JPRN-UMIN000017144招募中未知
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring. - Effects of long and short acting GLP-1 agonists on diabetic cardiovascular neuropathy and glycemic fluctuations. ELABORATE
Department of Endocrinology and Metabolism, Dokkyo Medical University0 个研究点目标入组 30 人开始时间: 2015年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Type 1 diabetes 2)Liver dysfunction (hepatic enzymes more than three times the upper limit of normal ranges) 3)A pregnant woman and/or a woman under breast-feeding 4)Impaired kidney function (serum crearinine greater than 1.3 mg/dl in men, 1.2 mg/dl in women) 5)Diabetic proliferative retinopathy 6)The patients who has an anamnesis of hypersensitivity to the ingredient of a trial drug 7)Cigarette smokers
研究者
相似试验
已完成
不适用
Comparison of the Effect of GLP-1 Receptor Agonists on Diurnal Glycemic Profiles in Patients with DiabetesInsulin-independent Diabetes MellitusJPRN-UMIN000007097Kitano Hospital, The Tazuke Kofukai Medical Research Institute40
进行中（未招募）
不适用
Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy10 patients (both gender) under treatment with premixed insulin (2-3 injections) and HbA1c>7% will be switched to basal insulin glargine (Lantus, once daily) and GLP-1 receptor agonist Lixisenatide (Lyxumia, once daily).EUCTR2013-005334-37-ATMedical University of Vienna / Medizinische Universität Wien
已完成
不适用
ong-term efficacy and safety of the GLP-1 receptor agonist liraglutide in Japanese patients with type 2 diabetes mellitus.Type 2 Diabetes mellitusJPRN-UMIN000037603akakinen clinic1,000
招募中
不适用
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
已完成
不适用
Study of the clinical effect of GLP-1 analogue for body weight, body fat, insulin secretion in patients with type 2 diabetesJPRN-UMIN000009638Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine130